
Countries like Germany, Switzerland and Japan have benefitted from an explosive growth in capital, but the US still dominates and the UK risks being left behind, our in-depth analysis shows.
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.
Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.
Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
ZGT has raised $48m from Tsinghua Holdings Capital, CAS Star and others, while University of Cambridge spinout Colorifix has pocketed $22.7m.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
UVC Partners has taken part in the round, which will allow Finn to expand further across the US while bolstering its market position in Europe.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Corporates continued to invest in real estate tech through 2022, unlike their traditional VC peers. We look at how this might play out.
Most corporate investors (74%) employ capital directly from the balance sheet of their corporate mothership but there are many variations.
Phlux Technology has raised $4.9m from investors including Foresight Williams Technology Funds as it looks to become the Nvidia of the sensor market.
SoftBank helped the on-demand laundry service push its valuation past $250m, a rare occurrence in a sector that's so far failed to catch fire.